Paper · 20826833
Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project.
Johansen D and 15 others. Cancer Epidemiol Biomarkers Prev, 2010. Cited by 88 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Papers, record 20826833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20826833
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Metabolic Syndrome | Major topic |
| Pancreatic Neoplasms | Major topic |
| Adult | |
| Blood Glucose | |
| Body Mass Index | |
| Cohort Studies | |
| Female | |
| Humans | |
| Incidence | |
| Male | |
| Middle Aged | |
| Proportional Hazards Models | |
| Prospective Studies | |
| Risk Factors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2007/09 | Cancer Research UK | United Kingdom | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by50
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,651,018 | Metabolic Syndrome and Pancreatic Cancer: Linking Insulin Resistance, Inflammation, and Carcinogenesis. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42651018 | PubMed |
| 41,543,183 | <p>Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)</p>. | Int J Oncol | 2026 | https://conductscience.org/library/papers/41543183 | PubMed |
| 41,009,312 | Relationships Between Psychological Health and Academic Performance Among Undergraduate Students in the Third Year of the COVID-19 Pandemic: A Cross-Sectional Study. | Behav Sci (Basel) | 2025 | https://conductscience.org/library/papers/41009312 | PubMed |
| 39,149,842 | Exploring the association between metabolic syndrome, its components and subsequent cancer incidence: A cohort study in Catalonia. | Cancer Med | 2024 | https://conductscience.org/library/papers/39149842 | PubMed |
| 38,415,709 | Next-generation therapies for pancreatic cancer. | Expert Rev Gastroenterol Hepatol | 2024 | https://conductscience.org/library/papers/38415709 | PubMed |
| 38,169,901 | Metabolic syndrome is linked to the incidence of pancreatic cancer. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/38169901 | PubMed |
| 37,113,491 | Correlation between pancreatic cancer and metabolic syndrome: A systematic review and meta-analysis. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37113491 | PubMed |
| 37,010,633 | Association between metabolic syndrome and gastric cancer risk: results from the Health Examinees Study. | Gastric Cancer | 2023 | https://conductscience.org/library/papers/37010633 | PubMed |
| 36,849,084 | Dietary Factors and Pancreatic Cancer Risk: An Umbrella Review of Meta-Analyses of Prospective Observational Studies. | Adv Nutr | 2023 | https://conductscience.org/library/papers/36849084 | PubMed |
| 36,647,199 | Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study. | J Natl Cancer Inst | 2023 | https://conductscience.org/library/papers/36647199 | PubMed |
1 to 10 of 50
See all 50 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20826833
GET https://conductscience.org/api/papers/v1/20826833/cited_by?page=2